Articles by SADOWSKY-KAUFMAN, MS, CCN, Karen


  • Low Dose Naltrexone: A versatile therapeutic agent

    Low Dose Naltrexone: A versatile therapeutic agent Every once in a while a medical therapy comes along that almost seems too good to be true. Such is the case with Low Dose Naltrexone (LDN). Naltrexone is an orally effective, long lasting opiate receptor antagonist. When prescribed in 50 mg doses (often up to 300 mgs), it is used in the management of alcohol and opioid dependence. Low Dos...
  • Vitamin D Deficiency Pandemic

    Vitamin D Deficiency Pandemic A note from the author For at least a decade, I have been touting to the importance of vitamin D. When I received my Master of Science degree in human nutrition from the University of New Haven in Connecticut in 1996, I carried with me some ideas and hypotheses that were considered well outside the mainstream of conventional scientific thinking at the time. I was convinced that the role vitamin D played in bone health was but the tip of an i...
  • Interview with Karen Sadowsky Kaufmann

    Interview with Karen Sadowsky Kaufmann IAS: Karen, can you please tell us about your credentials? Karen: Certainly. I have a Master of Science degree from the University of New Haven in Connecticut. I have worked in the nutrition and antiaging field for the past 10 years and have had the privilege of working with James South and Ward Dean, both of whom I consider to be mentors. IAS: Why did you choose this particular...
  • Vinpocetine - the ultimate neuroprotector

      Vinpocetine - the ultimate neuroprotector By Karen Sadowsky Kaufman, MS   Vinpocetine is synthesized from vincamine- an extract of the periwinkle plant, (also known as the Vinca minor). Vinpocetine is one of the most important Nootropics in our current armamentarium and has been used safely in parts of Europe and Japan since the 1970’s. Best known for its favorable effect on cerebral blood flow, in order to fully appreciate the benefits of Vinpoceti...
  • H1N1 and beating the flu virus

    H1N1 and beating the flu virus The flu season is upon us and talk of the new flu virus (H1N1) dominates every-news broadcast. Speculation as to the number of people expected to contract the flu and who exactly is in the high risk group changes daily. The availability of the traditional seasonal flu vaccine is not in question. The traditional vaccine contains three influenza viruses-one A (H3N2) virus, one A (H1N1) virus, and one B virus. The viruses in the vacc...
  • PYRIDOXAMINE: A Universal Weapon against aging

    PYRIDOXAMINE: A Universal Weapon against aging We are constantly being bombarded with messages from the media, the department of public health, and the World Health Organization (WHO) about how overweight and sedentary we have become. The incidence of obesity has reached epidemic proportions. Our growing waistlines coupled with our sedentary lifestyles have put us at risk for developing Type 2 diabetes as well as a host of other chronic degenerative diseases. I raise this issu...
  • DHEA A multi-functional antiaging hormone

    DHEA A multi-functional antiaging hormone Dehydroepiandrosterone (DHEA) burst into the public's awareness in 1996 with lots of fanfare from the media. Proclaimed as the fountain of youth DHEA was a feature story in Consumer Digest in May, 1996. Then in September it graced the covers of USA Today and Newsweek respectively. But at the time, many conservative scientists warned us to be cautious because the studies were preliminary. We were warned that the hormone may do more harm...
  • Beyond Cholesterol review by Karen Kaufman, MS

    Beyond Cholesterol Review Cardiovascular disease (CVD) in one of its various forms is the leading cause of morbidity (illness) and mortality (death) worldwide. It would be more accurate to say that atherosclerosis is the leading cause of morbidity and mortality. Arteriosclerosis or atherosclerosis, (the build up of plaque within the large and medium arteries of the body) is better known as coronary artery disease (CAD), carotid artery disease/ cerebrovascular disease (CVD), or...
  • Milnacipran: The next wonder drug?

    Milnacipran: The next wonder drug? Every once in a while, a new pharmaceutical drug appears that dramatically changes the medical approach to a particular illness. A good example of this is the antidepressant Prozac ®. Prozac was patented in 1977 and launched into the world marketplace in 1987. By the spring of 1990 Prozac had appeared on the cover of Newsweek, Time, and the New Yorker and was proclaimed the new "wonder drug," as well as a powe...